SCHEMBL7647879

SCHEMBL7647879

O=C(NC1CCCC1)c1ccc(F)c(F)c1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.59
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KDM1A O60341 1/20 0.55
MAOA P21397 1/20 0.55
LMNA P02545 3/20 0.51
HPGD P15428 3/20 0.51
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
HTT P42858 1/20 0.51
ADRA2A P08913 1/20 0.49
MCHR1 Q99705 1/20 0.49
GAA P10253 2/20 0.49
TAS1R3 Q7RTX0 1/20 0.49
TAS1R1 Q7RTX1 1/20 0.49
TAS1R2 Q8TE23 1/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7647584 0.97 EPHX2 (0.55) EPHX2NPC1RAB9ASMN1; SMN2KDM1A
SCHEMBL7645833 0.93 HPGD (0.55) EPHX2NPC1RAB9ASMN1; SMN2KDM1A
SCHEMBL10639906 0.80 CES2 (0.44) EPHX2HPGDADRA2AMCHR1GAA
SCHEMBL3170903 0.78 P2RX7 (0.57) NPC1RAB9ALMNAHPGDALDH1A1
SCHEMBL28465600 0.78 NPC1 (0.66) EPHX2NPC1RAB9ASMN1; SMN2KDM1A
SCHEMBL3455151 0.77 NPC1 (0.69) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL12181533 0.77 NPC1 (0.69) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL25690510 0.77 HPGD (0.53) NPC1RAB9ASMN1; SMN2KDM1AMAOA
SCHEMBL12121141 0.76 NPC1 (0.68) NPC1RAB9ASMN1; SMN2KDM1AMAOA
SCHEMBL3343582 0.76 NPC1 (0.55) NPC1RAB9ASMN1; SMN2KDM1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001035950-A2 BENZAMIDE THERAPEUTICS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-05-25 WO claimed
US-6486349-B1 Amide therapeutics and methods for treating inflammatory bowel disease CENTAUR PHARMACEUTICALS, INC. 2002-11-26 US disclosed
WO-2001035950-A2 BENZAMIDE THERAPEUTICS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2001-05-25 WO disclosed